Logo image of CLPS

CLPS INC (CLPS) Stock Fundamental Analysis

NASDAQ:CLPS - Nasdaq - KYG316421042 - Common Stock - Currency: USD

1.27  -0.08 (-5.93%)

Fundamental Rating

3

CLPS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the IT Services industry. While CLPS seems to be doing ok healthwise, there are quite some concerns on its profitability. CLPS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLPS has reported negative net income.
Of the past 5 years CLPS 4 years were profitable.
Of the past 5 years CLPS 4 years had a positive operating cash flow.
CLPS Yearly Net Income VS EBIT VS OCF VS FCFCLPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M

1.2 Ratios

The Return On Assets of CLPS (-2.41%) is worse than 60.26% of its industry peers.
With a Return On Equity value of -3.99%, CLPS perfoms like the industry average, outperforming 44.87% of the companies in the same industry.
CLPS has a Return On Invested Capital of 0.18%. This is comparable to the rest of the industry: CLPS outperforms 43.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLPS is below the industry average of 10.13%.
The 3 year average ROIC (7.26%) for CLPS is well above the current ROIC(0.18%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.41%
ROE -3.99%
ROIC 0.18%
ROA(3y)4.28%
ROA(5y)1.83%
ROE(3y)6.35%
ROE(5y)2.76%
ROIC(3y)7.26%
ROIC(5y)N/A
CLPS Yearly ROA, ROE, ROICCLPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

1.3 Margins

CLPS's Profit Margin has declined in the last couple of years.
CLPS has a Operating Margin (0.13%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLPS has declined.
CLPS has a Gross Margin of 21.85%. This is in the lower half of the industry: CLPS underperforms 74.36% of its industry peers.
In the last couple of years the Gross Margin of CLPS has declined.
Industry RankSector Rank
OM 0.13%
PM (TTM) N/A
GM 21.85%
OM growth 3Y-22.56%
OM growth 5Y-13.72%
PM growth 3Y-65.52%
PM growth 5Y-51.41%
GM growth 3Y-12.96%
GM growth 5Y-8.72%
CLPS Yearly Profit, Operating, Gross MarginsCLPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

CLPS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CLPS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLPS has been increased compared to 5 years ago.
The debt/assets ratio for CLPS has been reduced compared to a year ago.
CLPS Yearly Shares OutstandingCLPS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
CLPS Yearly Total Debt VS Total AssetsCLPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.46 indicates that CLPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
CLPS has a Altman-Z score of 2.46. This is comparable to the rest of the industry: CLPS outperforms 44.87% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that CLPS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.24, CLPS is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.46
ROIC/WACC0.02
WACC9.72%
CLPS Yearly LT Debt VS Equity VS FCFCLPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.26 indicates that CLPS has no problem at all paying its short term obligations.
CLPS has a Current ratio of 2.26. This is in the better half of the industry: CLPS outperforms 75.64% of its industry peers.
CLPS has a Quick Ratio of 2.26. This indicates that CLPS is financially healthy and has no problem in meeting its short term obligations.
CLPS has a Quick ratio of 2.26. This is in the better half of the industry: CLPS outperforms 75.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 2.26
CLPS Yearly Current Assets VS Current LiabilitesCLPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

CLPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -266.50%.
CLPS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -43.90% yearly.
CLPS shows a decrease in Revenue. In the last year, the revenue decreased by -4.90%.
Measured over the past years, CLPS shows a very strong growth in Revenue. The Revenue has been growing by 25.20% on average per year.
EPS 1Y (TTM)-266.5%
EPS 3Y-63.16%
EPS 5Y-43.9%
EPS Q2Q%-219.9%
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y18.93%
Revenue growth 5Y25.2%
Sales Q2Q%-6.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLPS Yearly Revenue VS EstimatesCLPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
CLPS Yearly EPS VS EstimatesCLPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLPS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLPS Price Earnings VS Forward Price EarningsCLPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

CLPS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLPS is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.18
CLPS Per share dataCLPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

CLPS has a Yearly Dividend Yield of 10.24%, which is a nice return.
Compared to an average industry Dividend Yield of 2.97, CLPS pays a better dividend. On top of this CLPS pays more dividend than 98.72% of the companies listed in the same industry.
CLPS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 10.24%

5.2 History

CLPS has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
CLPS Yearly Dividends per shareCLPS Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
CLPS Yearly Income VS Free CF VS DividendCLPS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M

More info and screens

CLPS INC

NASDAQ:CLPS (2/21/2025, 8:10:02 PM)

1.27

-0.08 (-5.93%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)10-17 2024-10-17
Earnings (Next)02-28 2025-02-28
Inst Owners0.47%
Inst Owner Change469.53%
Ins Owners21.52%
Ins Owner ChangeN/A
Market Cap35.36M
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 10.24%
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.56
EV/EBITDA 0.18
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.22
BVpS2.3
TBVpS2.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.41%
ROE -3.99%
ROCE 0.27%
ROIC 0.18%
ROICexc 0.29%
ROICexgc 0.3%
OM 0.13%
PM (TTM) N/A
GM 21.85%
FCFM N/A
ROA(3y)4.28%
ROA(5y)1.83%
ROE(3y)6.35%
ROE(5y)2.76%
ROIC(3y)7.26%
ROIC(5y)N/A
ROICexc(3y)12%
ROICexc(5y)N/A
ROICexgc(3y)13.18%
ROICexgc(5y)N/A
ROCE(3y)9.35%
ROCE(5y)N/A
ROICexcg growth 3Y-41.67%
ROICexcg growth 5Y-22.91%
ROICexc growth 3Y-37.89%
ROICexc growth 5Y-22.38%
OM growth 3Y-22.56%
OM growth 5Y-13.72%
PM growth 3Y-65.52%
PM growth 5Y-51.41%
GM growth 3Y-12.96%
GM growth 5Y-8.72%
F-ScoreN/A
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 11.1
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 2.26
Altman-Z 2.46
F-ScoreN/A
WACC9.72%
ROIC/WACC0.02
Cap/Depr(3y)827.59%
Cap/Depr(5y)529.35%
Cap/Sales(3y)4.95%
Cap/Sales(5y)3.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-266.5%
EPS 3Y-63.16%
EPS 5Y-43.9%
EPS Q2Q%-219.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y18.93%
Revenue growth 5Y25.2%
Sales Q2Q%-6.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.56%
EBIT growth 3Y-7.9%
EBIT growth 5Y8.02%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y152.34%
FCF growth 3Y17.26%
FCF growth 5YN/A
OCF growth 1Y203.44%
OCF growth 3Y17.87%
OCF growth 5YN/A